AlphaStocks
7.0
Consider Buy

Lantheus Holdings, Inc. (LNTH)

Health Care / Health Care Supplies

S&P MidCap 400

$75.69

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 5 of 5 models — high confidence

#93out of 1127 in Health Care

Is Lantheus Holdings, Inc. a Good Investment in 2026?

Lantheus Holdings, Inc. (LNTH) scores 7.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Lantheus Holdings, Inc. as Attractive (5/9). However, the Graham model rates it Caution — Significantly above fair value. Lantheus Holdings, Inc. currently trades below its estimated fair value of $112, suggesting potential upside. Lantheus Holdings, Inc. ranks #93 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.2ROE21.1Market Cap5B

Estimated Fair Value

$111.9732% below

Fair value above market price. ROE of 21% signals strong profitability. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Attractive

PEG 0.9 · Fast Grower

Greenblatt

Attractive

Top half (rank 26%)

Frequently Asked Questions

Is Lantheus Holdings, Inc. (LNTH) a good investment?
Based on AlphaStocks' composite analysis, Lantheus Holdings, Inc. (LNTH) scores 7.0 out of 10, earning a Consider Buy rating. This places it above average across most investment dimensions. Fair value above market price. ROE of 21% signals strong profitability. P/E of 22x is moderate for this quality level.
What is Lantheus Holdings, Inc.'s Piotroski F-Score?
Lantheus Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is LNTH overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $112, LNTH appears undervalued. The stock currently trades 32% below its estimated fair value. Fair value above market price. ROE of 21% signals strong profitability. P/E of 22x is moderate for this quality level.
How does LNTH compare to other Health Care stocks?
Lantheus Holdings, Inc. ranks #93 out of 1127 stocks in the Health Care sector, placing it in the top 8% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about LNTH?
AlphaStocks evaluates LNTH using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Attractive; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 7.0/10.

Similar Stocks

PARRFTIAZN

Compare LNTH with

LNTH vs PARRLNTH vs FTILNTH vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer